EBITDA Growth
24.99%
TTM · Period ending:
SURG EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported24.99%period ending
Latest reported24.99%period ending
SURG TTM EBITDA YoY % (-39.13% → 24.99%)
Year-over-year change
High-resolution chart · PNG
SURG ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 24.9877% | |
| 27.1586% | |
| 19.7771% | |
| -95.1242% | |
| -6,374.7116% | |
| -394.516% | |
| -305.2531% | |
| -189.1152% | |
| -94.9589% | |
| 106.1879% | |
| 729.1447% | |
| 523.5911% | |
| 402.4603% | |
| 402.7223% | |
| 147.5311% | |
| -104.1585% | |
| -43.5014% | |
| 60.1556% | |
| 14.0562% | |
| 61.0753% | |
| 50.7192% | |
| 14.0875% | |
| 19.3366% | |
| -10.3453% | |
| -28.3786% | |
| -157.4719% | |
| -556.0368% | |
| -2,216.3277% | |
| -1,249.9552% | |
| -1,168.8642% | |
| 22.4085% | |
| 110.6299% | |
| 115.721% | |
| 91.6659% | |
| 42.3918% | |
| -23.2503% | |
| -54.2862% | |
| -138.5538% | |
| -205.7473% | |
| -1,895.4755% | |
| -6,184.5577% | |
| -2,909.0609% | |
| -15,072.0234% | |
| -1,179.6918% | |
| -291.9063% | |
| 396.5152% | |
| 111.9025% | |
| 72.0939% | |
| 78.5701% | |
| 39.8987% | |
| 42.4776% | |
| 92.7109% | |
| 93.3472% | |
| 96.2128% | |
| 87.6875% | |
| -15.6927% | |
| -65.8731% | |
| -72.9339% | |
| 7.7696% | |
| 52.401% | |
| 60.8529% | |
| 56.3612% | |
| 30.6744% | |
| 40.722% | |
| 30.4372% | |
| 19.3765% | |
| -88.7011% | |
| -1,200.136% | |
| -2,603.0074% | |
| -692.4274% | |
| -39.1285% |